Min John's most recent trade in Wendy`s Co - Ordinary Shares - Class A was a trade of 182 Restricted Stock Units done . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wendy`s Co - Ordinary Shar... | John Min | Chief Legal Ofcr & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2025 | 182 | 14,724 | - | - | Restricted Stock Units | |
| NPK International Inc. | John C. Minge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 15,097 | 245,384 (0%) | 0% | 0 | Common Stock | |
| Wendy`s Co - Ordinary Shar... | John Min | Chief Legal Ofcr & Secretary | Purchase of securities on an exchange or from another person at price $ 11.98 per share. | 09 May 2025 | 1,000 | 1,304 (0%) | 0% | 12.0 | 11,980 | Common Stock |
| Wendy`s Co - Ordinary Shar... | John Min | Chief Legal Ofcr & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 234 | 14,542 | - | - | Restricted Stock Units | |
| Wendy`s Co - Ordinary Shar... | John Min | Chief Legal Ofcr & Secretary | 17 Mar 2025 | 4 | 304 (0%) | 0% | 18.8 | 75 | Common Stock | |
| NPK International Inc. | John C. Minge | Director | Purchase of securities on an exchange or from another person at price $ 5.38 per share. | 05 Mar 2025 | 10,000 | 230,287 (0%) | 0% | 5.4 | 53,800 | Common Stock |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 122,222 | 447,070 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 10 Feb 2025 | 38,938 | 408,132 (0%) | 0% | 1.8 | 68,531 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 40,187 | 324,848 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 4.27 per share. | 12 Aug 2024 | 9,910 | 284,661 (0%) | 0% | 4.3 | 42,316 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.45 per share. | 20 May 2024 | 17,404 | 294,571 (0%) | 0% | 6.5 | 112,256 | Class A Common Stock |
| NPK International Inc. | John C. Minge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 16,108 | 220,287 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 32,752 | 311,975 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 32,752 | 0 | - | - | Performance-based Restricted Stock Unit | |
| Kellanova | John Min | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 4,960 | 4,960 | - | - | Restricted Stock Units | |
| Kellanova | John Min | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,205 | 8,144 (0%) | 0% | 0 | Common | |
| Kellanova | Min John | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 2,205 | 0 | - | - | Restricted Stock Units | |
| Kellanova | Min John | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 952 | 8,376 (0%) | 0% | 0 | Common | |
| Kellanova | John Min | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 952 | 0 | - | - | Restricted Stock Units | |
| Kellanova | Min John | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.47 per share. | 16 Feb 2024 | 721 | 7,423 (0%) | 0% | 55.5 | 39,994 | Common |
| Kellanova | John Min | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.47 per share. | 16 Feb 2024 | 277 | 8,099 (0%) | 0% | 55.5 | 15,365 | Common |
| Ironwood Pharmaceuticals I... | Minardo John | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 54,427 | 279,223 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 12 Feb 2024 | 47,380 | 224,796 (0%) | 0% | 15.2 | 722,071 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | Minardo John | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 27,214 | 27,214 | - | - | Performance-based Restricted Stock Unit | |
| Ironwood Pharmaceuticals I... | Minardo John | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 79,981 | 272,176 (0%) | 0% | 0 | Class A Common Stock | |
| Kellanova | John Min | Chief Legal Officer | Other type of transaction at price $ 0.00 per share. | 30 Dec 2023 | 31 | 3,097 | - | - | Restricted Stock Units | |
| Kellanova | Min John | Chief Legal Officer | Other type of transaction at price $ 0.00 per share. | 30 Dec 2023 | 24 | 2,373 | - | - | Restricted Stock Units | |
| Kellanova | John Min | Chief Legal Officer | Other type of transaction at price $ 0.00 per share. | 30 Dec 2023 | 22 | 2,205 | - | - | Restricted Stock Units | |
| Kellanova | John Min | Chief Legal Officer | Other type of transaction at price $ 0.00 per share. | 30 Dec 2023 | 9 | 952 | - | - | Restricted Stock Units | |
| Kellanova | Min John | Chief Legal Officer | Other type of transaction at price $ 0.00 per share. | 30 Dec 2023 | 7 | 735 | - | - | Restricted Stock Units | |
| Kellanova | John Min | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2023 | 3,066 | 3,066 | - | - | Restricted Stock Units | |
| Kellanova | John Min | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2023 | 2,183 | 2,183 | - | - | Restricted Stock Units | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.04 per share. | 14 Aug 2023 | 7,045 | 192,195 (0%) | 0% | 10.0 | 70,732 | Class A Common Stock |
| NPK International Inc. | John C. Minge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 32,134 | 204,179 (0%) | 0% | 0 | Common Stock | |
| NPK International Inc. | John C. Minge | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 15 Mar 2023 | 5,000 | 167,045 (0%) | 0% | 4 | 20,000 | Common Stock |
| NPK International Inc. | John C. Minge | Director | Purchase of securities on an exchange or from another person at price $ 4.05 per share. | 15 Mar 2023 | 5,000 | 172,045 (0%) | 0% | 4.1 | 20,250 | Common Stock |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 65,502 | 199,240 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 32,751 | 32,751 | - | - | Performance-based Restricted Stock Units | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 27 Feb 2023 | 3,415 | 133,738 (0%) | 0% | 11.3 | 38,624 | Class A Common Stock |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 27 Feb 2023 | 3,282 | 137,153 (0%) | 0% | 11.4 | 37,448 | Class A Common Stock |
| NPK International Inc. | John C. Minge | Director | Purchase of securities on an exchange or from another person at price $ 3.64 per share. | 21 Nov 2022 | 5,000 | 162,045 (0%) | 0% | 3.6 | 18,200 | Common Stock |
| NPK International Inc. | John C. Minge | Director | Purchase of securities on an exchange or from another person at price $ 3.95 per share. | 10 Nov 2022 | 5,000 | 157,045 (0%) | 0% | 3.9 | 19,741 | Common Stock |
| NPK International Inc. | John C. Minge | Director | Purchase of securities on an exchange or from another person at price $ 2.66 per share. | 16 Aug 2022 | 15,000 | 152,045 (0%) | 0% | 2.7 | 39,851 | Common Stock |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 11.77 per share. | 15 Aug 2022 | 7,330 | 140,435 (0%) | 0% | 11.8 | 86,274 | Class A Common Stock |
| NPK International Inc. | John C. Minge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 36,496 | 137,045 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharmaceuticals I... | John Minardo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 79,892 | 79,892 (0%) | 0% | 0 | Class A Common Stock | |
| NPK International Inc. | John C. Minge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 34,299 | 100,549 (0%) | 0% | 0 | Common Stock |